Stephen Oh, M.D., Ph.D., is Professor of Medicine and Co-Chief of the Division of Hematology at Washington University School of Medicine. Dr. Oh’s clinical practice and research efforts are focused on hematologic malignancies including myeloproliferative neoplasms (MPNs). His laboratory employs patient samples and animal models to investigate fundamental mechanisms driving the initiation, development, and progression of MPNs, with a particular focus on inflammatory cytokine signaling networks in MPNs. Dr. Oh has extensive clinical experience in the diagnosis and management of MPN patients and has contributed to numerous clinical trials investigating novel targeted therapies for MPN patients. The long-term objective of his work is to translate the findings from his laboratory research into improved therapies for MPN patients.
Stephen Oh MD, PhD
Washington University in St. Louis
St. Louis, Missouri
United States
Project Title
Exploiting Novel Therapeutic Vulnerabilities in Chronic Myelomonocytic Leukemia Therapeutic RSK1 Targeting in Myeloid Malignancies
Program
Academic Clinical Trials Program (ACT)
CMML Initiative